NURS 6521 Advanced Pharmacology Final Exam
V3 Official Practice Exam Actual Exam
2026/2027 with Detailed Rationales | Complete
Exam-Style Questions | Pass Guaranteed – A+
Graded
═════════════════════════════════════
═
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS Q1 – Q15
══════════════════════════════════════
Question 1 of 100
72-year-old male with cirrhosis and ascites has a serum albumin level of 2.0 g/dL and
A
is started on warfarin for atrial fibrillation. The nurse practitioner understands that low
albumin levels will have what effect on the active drug concentration?
. Increase the drug's metabolism, leading to subtherapeutic INR levels.
A
B. Decrease the drug's absorption, requiring an alternative anticoagulant route.
C. Increase the free drug fraction, elevating the risk of bleeding. ✓ CORRECT
D. Enhance protein binding, reducing the overall pharmacologic effect.
orrect Answer: C
C
Rationale: Warfarin is highly protein-bound, so low serum albumin increases the free
drug fraction, leading to higher active drug levels and a greater risk of toxicity.
Metabolizing the drug faster is incorrect because hepatic impairment actually slows
metabolism, further compounding drug accumulation. Monitoring INR closely is critical
when albumin levels are low.
Question 2 of 100
45-year-old female is prescribed a medication with a half-life of 12 hours. She asks
A
the nurse practitioner how long it will take for the medication to reach steady-state
levels in her bloodstream.
. 12 to 24 hours
A
B. 24 to 36 hours
, . 36 to 48 hours
C
D. 48 to 60 hours ✓ CORRECT
orrect Answer: D
C
Rationale: Steady-state is achieved after 4 to 5 half-lives, so multiplying 12 hours by 4 to
5 yields 48 to 60 hours. Achieving steady-state in 24 hours is incorrect because it
represents only two half-lives, which is insufficient for consistent therapeutic levels.
Patients should be advised to take the medication consistently to reach this state.
Question 3 of 100
patient with a history of epilepsy is taking phenytoin, which exhibits zero-order
A
kinetics at high doses. The nurse practitioner reviews the patient's labs and notes a
slightly elevated phenytoin level. What is the clinical implication of zero-order kinetics in
this scenario?
. A small increase in dose can cause a disproportionate increase in serum drug levels.
A
✓ CORRECT
B. The drug is eliminated at a constant fractional rate regardless of the dose.
C. Doubling the dose will reliably double the serum concentration of the drug.
D. The medication will reach steady-state precisely after 4 half-lives.
orrect Answer: A
C
Rationale: With zero-order kinetics, enzymes become saturated, meaning a constant
amount of drug is eliminated per unit of time rather than a constant fraction. Eliminating
a constant fraction of the drug is incorrect because that describes first-order kinetics,
which does not apply to high-dose phenytoin. Dose adjustments must be made in very
small increments to avoid toxicity.
Question 4 of 100
60-year-old male is prescribed metoprolol for hypertension but experiences poor
A
therapeutic response despite standard dosing. Genetic testing reveals he is a CYP2D6
ultra-rapid metabolizer. What is the most appropriate clinical action?
. Discontinue metoprolol and switch to a non-dihydropyridine calcium channel blocker.
A
B. Increase the metoprolol dose or switch to an alternative antihypertensive. ✓
CORRECT
C. Add a CYP2D6 inhibitor to slow the metabolism of the metoprolol.
D. Reduce the metoprolol dose to prevent accumulation of toxic metabolites.
, orrect Answer: B
C
Rationale: CYP2D6 ultra-rapid metabolizers break down metoprolol too quickly, leading
to subtherapeutic levels and poor blood pressure control. Decreasing the metoprolol
dose is incorrect because it would further lower plasma concentrations and worsen
therapeutic failure. Pharmacogenomic testing can guide safer and more effective
dosing strategies.
Question 5 of 100
nurse practitioner is comparing two medications for a patient with severe pain. Drug X
A
has a median effective dose (ED50) of 5 mg, and Drug Y has an ED50 of 50 mg. Both
drugs have the same median toxic dose (TD50). Which statement best describes the
comparison between these two drugs?
. Drug X has a higher efficacy than Drug Y.
A
B. Drug Y is safer than Drug X due to the higher dose requirement.
C. Drug X is more potent than Drug Y. ✓ CORRECT
D. Drug Y has a narrower therapeutic index than Drug X.
orrect Answer: C
C
Rationale: Potency refers to the dose required to produce a specific effect, so a lower
ED50 indicates higher potency. Drug X having higher efficacy is incorrect because
efficacy refers to the maximum effect achievable, not the dose required to achieve it. A
lower dose does not necessarily mean a better clinical outcome.
Question 6 of 100
55-year-old female is started on a medication that acts as a partial agonist at a
A
specific receptor. What is the expected clinical effect of this medication if given alone
versus when given with a full agonist?
. Produces a maximal response alone and enhances the full agonist when given
A
together.
B. Produces no clinical effect alone but blocks the full agonist when given together.
C. Produces a submaximal response alone and blocks the full agonist when given
together. ✓ CORRECT
D. Produces a submaximal response alone and enhances the full agonist when given
together.
Correct Answer: C
, ationale: A partial agonist produces a submaximal response when binding to a
R
receptor and can act as a competitive antagonist in the presence of a full agonist.
Producing a maximal response alone is incorrect because partial agonists lack the
intrinsic activity to fully activate the receptor. This mechanism is utilized in drugs like
varenicline for smoking cessation.
Question 7 of 100
68-year-old male with severe renal impairment is prescribed a drug that is 80% cleared
A
by the kidneys. The medication has a narrow therapeutic index. What is the most
appropriate prescribing strategy to ensure patient safety?
. Reduce the dose and monitor serum drug levels closely. ✓ CORRECT
A
B. Administer the standard dose but extend the dosing interval only.
C. Administer a loading dose followed by standard maintenance dosing.
D. Discontinue the medication and switch to a hepatically cleared alternative.
orrect Answer: A
C
Rationale: Renal impairment decreases the clearance of renally excreted drugs,
necessitating dose reduction and therapeutic drug monitoring to prevent toxicity.
Administering the standard dose is incorrect because it ignores the reduced renal
clearance and significantly increases the risk of adverse effects. Narrow therapeutic
index drugs require precise dosing adjustments.
Question 8 of 100
patient is receiving a drug that undergoes extensive hepatic first-pass metabolism.
A
The nurse practitioner switches the medication from oral to sublingual administration.
What is the primary pharmacokinetic reason for this route change?
. To slow down the absorption and prolong the duration of action.
A
B. To bypass the liver and increase systemic bioavailability. ✓ CORRECT
C. To bypass the gastrointestinal tract and prevent drug degradation by stomach acid.
D. To enhance renal excretion and reduce the risk of systemic toxicity.
orrect Answer: B
C
Rationale: Sublingual administration allows the drug to be absorbed directly into the
systemic circulation, bypassing hepatic first-pass metabolism and increasing
bioavailability. Slowing down absorption is incorrect because sublingual routes actually
provide faster onset of action compared to oral ingestion. This route is often used for
drugs like nitroglycerin.
V3 Official Practice Exam Actual Exam
2026/2027 with Detailed Rationales | Complete
Exam-Style Questions | Pass Guaranteed – A+
Graded
═════════════════════════════════════
═
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS Q1 – Q15
══════════════════════════════════════
Question 1 of 100
72-year-old male with cirrhosis and ascites has a serum albumin level of 2.0 g/dL and
A
is started on warfarin for atrial fibrillation. The nurse practitioner understands that low
albumin levels will have what effect on the active drug concentration?
. Increase the drug's metabolism, leading to subtherapeutic INR levels.
A
B. Decrease the drug's absorption, requiring an alternative anticoagulant route.
C. Increase the free drug fraction, elevating the risk of bleeding. ✓ CORRECT
D. Enhance protein binding, reducing the overall pharmacologic effect.
orrect Answer: C
C
Rationale: Warfarin is highly protein-bound, so low serum albumin increases the free
drug fraction, leading to higher active drug levels and a greater risk of toxicity.
Metabolizing the drug faster is incorrect because hepatic impairment actually slows
metabolism, further compounding drug accumulation. Monitoring INR closely is critical
when albumin levels are low.
Question 2 of 100
45-year-old female is prescribed a medication with a half-life of 12 hours. She asks
A
the nurse practitioner how long it will take for the medication to reach steady-state
levels in her bloodstream.
. 12 to 24 hours
A
B. 24 to 36 hours
, . 36 to 48 hours
C
D. 48 to 60 hours ✓ CORRECT
orrect Answer: D
C
Rationale: Steady-state is achieved after 4 to 5 half-lives, so multiplying 12 hours by 4 to
5 yields 48 to 60 hours. Achieving steady-state in 24 hours is incorrect because it
represents only two half-lives, which is insufficient for consistent therapeutic levels.
Patients should be advised to take the medication consistently to reach this state.
Question 3 of 100
patient with a history of epilepsy is taking phenytoin, which exhibits zero-order
A
kinetics at high doses. The nurse practitioner reviews the patient's labs and notes a
slightly elevated phenytoin level. What is the clinical implication of zero-order kinetics in
this scenario?
. A small increase in dose can cause a disproportionate increase in serum drug levels.
A
✓ CORRECT
B. The drug is eliminated at a constant fractional rate regardless of the dose.
C. Doubling the dose will reliably double the serum concentration of the drug.
D. The medication will reach steady-state precisely after 4 half-lives.
orrect Answer: A
C
Rationale: With zero-order kinetics, enzymes become saturated, meaning a constant
amount of drug is eliminated per unit of time rather than a constant fraction. Eliminating
a constant fraction of the drug is incorrect because that describes first-order kinetics,
which does not apply to high-dose phenytoin. Dose adjustments must be made in very
small increments to avoid toxicity.
Question 4 of 100
60-year-old male is prescribed metoprolol for hypertension but experiences poor
A
therapeutic response despite standard dosing. Genetic testing reveals he is a CYP2D6
ultra-rapid metabolizer. What is the most appropriate clinical action?
. Discontinue metoprolol and switch to a non-dihydropyridine calcium channel blocker.
A
B. Increase the metoprolol dose or switch to an alternative antihypertensive. ✓
CORRECT
C. Add a CYP2D6 inhibitor to slow the metabolism of the metoprolol.
D. Reduce the metoprolol dose to prevent accumulation of toxic metabolites.
, orrect Answer: B
C
Rationale: CYP2D6 ultra-rapid metabolizers break down metoprolol too quickly, leading
to subtherapeutic levels and poor blood pressure control. Decreasing the metoprolol
dose is incorrect because it would further lower plasma concentrations and worsen
therapeutic failure. Pharmacogenomic testing can guide safer and more effective
dosing strategies.
Question 5 of 100
nurse practitioner is comparing two medications for a patient with severe pain. Drug X
A
has a median effective dose (ED50) of 5 mg, and Drug Y has an ED50 of 50 mg. Both
drugs have the same median toxic dose (TD50). Which statement best describes the
comparison between these two drugs?
. Drug X has a higher efficacy than Drug Y.
A
B. Drug Y is safer than Drug X due to the higher dose requirement.
C. Drug X is more potent than Drug Y. ✓ CORRECT
D. Drug Y has a narrower therapeutic index than Drug X.
orrect Answer: C
C
Rationale: Potency refers to the dose required to produce a specific effect, so a lower
ED50 indicates higher potency. Drug X having higher efficacy is incorrect because
efficacy refers to the maximum effect achievable, not the dose required to achieve it. A
lower dose does not necessarily mean a better clinical outcome.
Question 6 of 100
55-year-old female is started on a medication that acts as a partial agonist at a
A
specific receptor. What is the expected clinical effect of this medication if given alone
versus when given with a full agonist?
. Produces a maximal response alone and enhances the full agonist when given
A
together.
B. Produces no clinical effect alone but blocks the full agonist when given together.
C. Produces a submaximal response alone and blocks the full agonist when given
together. ✓ CORRECT
D. Produces a submaximal response alone and enhances the full agonist when given
together.
Correct Answer: C
, ationale: A partial agonist produces a submaximal response when binding to a
R
receptor and can act as a competitive antagonist in the presence of a full agonist.
Producing a maximal response alone is incorrect because partial agonists lack the
intrinsic activity to fully activate the receptor. This mechanism is utilized in drugs like
varenicline for smoking cessation.
Question 7 of 100
68-year-old male with severe renal impairment is prescribed a drug that is 80% cleared
A
by the kidneys. The medication has a narrow therapeutic index. What is the most
appropriate prescribing strategy to ensure patient safety?
. Reduce the dose and monitor serum drug levels closely. ✓ CORRECT
A
B. Administer the standard dose but extend the dosing interval only.
C. Administer a loading dose followed by standard maintenance dosing.
D. Discontinue the medication and switch to a hepatically cleared alternative.
orrect Answer: A
C
Rationale: Renal impairment decreases the clearance of renally excreted drugs,
necessitating dose reduction and therapeutic drug monitoring to prevent toxicity.
Administering the standard dose is incorrect because it ignores the reduced renal
clearance and significantly increases the risk of adverse effects. Narrow therapeutic
index drugs require precise dosing adjustments.
Question 8 of 100
patient is receiving a drug that undergoes extensive hepatic first-pass metabolism.
A
The nurse practitioner switches the medication from oral to sublingual administration.
What is the primary pharmacokinetic reason for this route change?
. To slow down the absorption and prolong the duration of action.
A
B. To bypass the liver and increase systemic bioavailability. ✓ CORRECT
C. To bypass the gastrointestinal tract and prevent drug degradation by stomach acid.
D. To enhance renal excretion and reduce the risk of systemic toxicity.
orrect Answer: B
C
Rationale: Sublingual administration allows the drug to be absorbed directly into the
systemic circulation, bypassing hepatic first-pass metabolism and increasing
bioavailability. Slowing down absorption is incorrect because sublingual routes actually
provide faster onset of action compared to oral ingestion. This route is often used for
drugs like nitroglycerin.
